ShangPharma Forms Drug Translation Collaboration with UCSF

ShangPharma Innovation, Inc. (SPII) will collaborate with the University of California San Francisco by providing UCSF scientists with funding and other support to accelerate the development of promising life science discoveries. ShangPharma plans to bring industrial development to UCSF's academic projects. SPII agreed to provide "several years of funding" to underwrite R&D in UCSF labs. It will also pay for CRO services at ChemPartner for joint SPII-UCSF projects. SPII and UCSF will own the projects jointly, though no further financial details were provided. More details.... Share this with colleagues: // //